Literature DB >> 25240947

Epigenetic diversity in hematopoietic neoplasms.

Rita Shaknovich1, Subhajyoti De2, Franziska Michor3.   

Abstract

Tumor cell populations display a remarkable extent of variability in non-genetic characteristics such as DNA methylation, histone modification patterns, and differentiation levels of individual cells. It remains to be elucidated whether non-genetic heterogeneity is simply a byproduct of tumor evolution or instead a manifestation of a higher-order tissue organization that is maintained within the neoplasm to establish a differentiation hierarchy, a favorable microenvironment, or a buffer against changing selection pressures during tumorigenesis. Here, we review recent findings on epigenetic diversity, particularly heterogeneity in DNA methylation patterns in hematologic malignancies. We also address the implications of epigenetic heterogeneity for the clonal evolution of tumors and discuss its effects on gene expression and other genome functions in cancer.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Epigenetics; Heterogeneity; Lymphoma

Mesh:

Year:  2014        PMID: 25240947     DOI: 10.1016/j.bbcan.2014.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.

Authors:  Xin Zhao; Xin Tian; Sachiko Kajigaya; Caroline R Cantilena; Stephen Strickland; Bipin N Savani; Sanjay Mohan; Xingmin Feng; Keyvan Keyvanfar; Neil Dunavin; Danielle M Townsley; Bogdan Dumitriu; Minoo Battiwalla; Katayoun Rezvani; Neal S Young; A John Barrett; Sawa Ito
Journal:  Br J Haematol       Date:  2016-07-19       Impact factor: 6.998

Review 2.  Genetic and epigenetic heterogeneity in acute myeloid leukemia.

Authors:  Sheng Li; Christopher E Mason; Ari Melnick
Journal:  Curr Opin Genet Dev       Date:  2016-05-07       Impact factor: 5.578

3.  Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas.

Authors:  Rossella Marullo; Sarah C Rutherford; John P Leonard; Leandro Cerchietti
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

Review 4.  Clonal evolution in leukemia.

Authors:  Adolfo A Ferrando; Carlos López-Otín
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

Review 5.  An evolutionary approach to clonally complex hematologic disorders.

Authors:  Emily Schwenger; Ulrich Steidl
Journal:  Blood Cancer Discov       Date:  2021-04-15

Review 6.  Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis.

Authors:  Pilar M Dominguez; Rita Shaknovich
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

7.  DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.

Authors:  Serena Ferraresso; Arianna Aricò; Tiziana Sanavia; Silvia Da Ros; Massimo Milan; Luciano Cascione; Stefano Comazzi; Valeria Martini; Mery Giantin; Barbara Di Camillo; Sandro Mazzariol; Diana Giannuzzi; Laura Marconato; Luca Aresu
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

Review 8.  Genetic and epigenetic determinants of diffuse large B-cell lymphoma.

Authors:  Tanner J Bakhshi; Philippe T Georgel
Journal:  Blood Cancer J       Date:  2020-12-04       Impact factor: 11.037

9.  INTS11 regulates hematopoiesis by promoting PRC2 function.

Authors:  Peng Zhang; Pinpin Sui; Shi Chen; Ying Guo; Ying Li; Guo Ge; Ganqian Zhu; Hui Yang; Cody M Rogers; Patrick Sung; Stephen D Nimer; Mingjiang Xu; Feng-Chun Yang
Journal:  Sci Adv       Date:  2021-09-01       Impact factor: 14.136

Review 10.  EZH2 in normal hematopoiesis and hematological malignancies.

Authors:  Laurie Herviou; Giacomo Cavalli; Guillaume Cartron; Bernard Klein; Jérôme Moreaux
Journal:  Oncotarget       Date:  2016-01-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.